FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to the field of pharmaceutics and medicine and deals with the application of the von Willebrand factor in a combination with factor VIII for the treatment and/or prevention of a haemorrhage episode, associated with thrombopathy, induced with platelet-inhibiting substances, the where platelet-inhibiting substance is represented by an inhibitor of ADP receptor or a combination of the inhibitor of FDP receptor and cyclooxygenase inhibitor. The invention also relates to a composition and a method of treatment and/or prevention of a disorder, associated with the haemorrhage, associated with thrombopathy, induced by the platelet-inhibiting substances.
EFFECT: group of inventions provides the reduction or prevention of undesirable instances of the haemorrhage after the introduction of anticoagulants or fibrinolytics.
19 cl, 6 dwg, 5 tbl, 2 ex
| Title |
Year |
Author |
Number |
| COMPOSITIONS AND METHODS OF TREATMENT OF COMPLICATIONS AND DISORDERS ASSOCIATED WITH THE VON WILLEBRAND FACTOR |
2018 |
- Zhu, Shuhao
- Gilbert, James C.
|
RU2806844C2 |
| METHOD FOR PRODUCING CONCENTRATED VON WILLEBRAND FACTOR OR FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX AND APPLYING THEREOF |
2008 |
- Ristol Debart Pere
- Faro Tomas Marija Mersedes
- Zhorkera Nieto Khuan Ignasio
|
RU2417096C2 |
| PREPARATION CONTAINING VIII FACTOR AND VON WILLEBRAND FACTOR PEPTIDES |
2015 |
- Kannicht, Christoph
- Solecka, Barbara
- Kohla, Guido
- Winge, Stefan
|
RU2714154C2 |
| MODIFIED VON WILLEBRAND FACTOR WITH PROLONGED HALF-CYCLE IN VIVO, USING IT AND METHODS FOR PREPARING |
2009 |
- Vajmer Tomas
- Shul'Te Shtefan
- Mettsner Khubert
- Krontkhaler Ul'Rikh
- Lind Khol'Ger
- Lang Vigand
|
RU2528855C2 |
| METHOD OF PREVENTION OF BLEEDING CAUSED BY THE APPLICATION OF ANTIAGREGANTS, EXPERIMENT STAGE |
2017 |
- Momot Andrej Pavlovich
- Vdovin Vyacheslav Mikhajlovich
- Tolstokorov Igor Gennadevich
- Shakhmatov Igor Ilich
- Orekhov Dmitrij Andreevich
- Shevchenko Valentin Olegovich
- Lycheva Natalya Aleksandrovna
- Fokht Eduard Vernerovich
- Makarov Anatolij Nikolaevich
|
RU2645630C1 |
| PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VIIA AND FACTOR XIII |
2001 |
- Petersen Lars Kristian
- Khedner Ulla
- Rejk'Er Rasmus
|
RU2272648C2 |
| FACTOR II AND FIBRINOGEN FOR TREATMENT OF HAEMOSTATIC DISORDERS |
2011 |
- Lovgren Ann
- Khansson Kenni
|
RU2606155C2 |
| ISOLATED GLYCOPROTEIN IB ALPHA POLYPEPTIDE OF HUMAN THROMBOCYTES, FUSED PROTEIN, DNA MOLECULE (VERSIONS), EXPRESSION VECTOR (VERSIONS), CELL (VERSIONS), POLYPEPTIDE EXPRESSION METHOD, FUSED PROTEIN EXPRESSION METHOD, PHARMACEUTICAL COMPOSITION (VERSIONS), METHOD OF INHIBITING BODING OF BLOOD CELLS TO BIOLOGICAL TISSUE IN BIOLOGICAL SYSTEM, METHOD OF INHIBITING BONDING OF PROTEIN TO BIOLOGICAL TISSUE IN BIOLOGICAL SYSTEM AND DISORDER TREATMENT METHOD |
2004 |
- Sho Grej
- Sako Dajann S.
- Kumar Ravindra
- Sjuj Tszin'
|
RU2403262C2 |
| METHODS OF TREATING OR PREVENTING THROMBOSIS OR EMBOLISM |
2011 |
|
RU2611662C2 |
| PREPARATIONS CONTAINING VON WILLEBRAND FACTOR (vWF) AND METHODS, KITS AND APPLICATIONS RELATED TO THEM |
2010 |
|
RU2579977C2 |
